Skip to search formSkip to main contentSkip to account menu

sculptra

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Neuropathic Pain Following Poly-L-Lactic Acid (Sculptra) Injection.
Injectable fillers have become a prevalent means of facial rejuvenation and volume expansion. While typically well tolerated… 
Review
2014
Review
2014
Evaluating MR Imaging and Quality of Life Semipermanent Filler Treatment of HIV-Positive Patients With Facial Lipoatrophy: Long-Term Follow-up
Background: Injectable fillers such as poly-L-lactic acid (PLLA) and calcium hydroxylapatite (CaHA) have shown promising results… 
2012
2012
Psychological morbidity and facial volume in HIV lipodystrophy: quantification of treatment outcome.
2012
2012
The "skinny"on Sculptra: a practical primer to volumization with poly-L-lactic acid.
Poly-L-lactic acid (PLLA) is a biostimulatory agent that can correct bony and soft tissue facial deficiencies by producing… 
2011
2011
Rajeunissement facial par l’acide L-polylactique : à propos de 298 cas consécutifs
2011
2011
[Facial rejuvenation using L-polylactic acid: about 298 successive cases].
Review
2007
Review
2007
Minimizing the risk of adverse events with injectable poly-L-lactic acid
Injectable poly-L-lactic acid (SculptraAE) is an effective and durable treatment for volume correction/restoration (in people… 
2006
2006
HIV-related lipodystrophy and facial lipoatrophy: the role of Restylane SubQ in reversing facial wasting.
2006
2006
Treatment of postoperative soft tissue loss with injectable poly-L-lactic acid.
We present a case of a 40-year-old woman with a history of a wide local excision for a melanoma and subsequent postoperative soft… 
Review
2006
Review
2006
Use of sculptra mark in esthetic rejuvenation.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)